Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.
about
Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@ast
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@en
type
label
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@ast
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@en
prefLabel
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@ast
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@en
P2093
P2860
P356
P1433
P1476
Genetic variation in CYB5R3 is ...... eceiving nitric oxide therapy.
@en
P2093
Allison M Momany
Jeffrey C Murray
Kelli K Ryckman
Lindsey A Knake
Tamara D Busch
Tyson D Fuller
P2860
P2888
P304
P356
10.1038/PR.2014.206
P407
P577
2014-12-18T00:00:00Z
P5875
P6179
1040991614